Question 1

What is the catalog number for PF-04691502?

Accepted Answer

The catalog number for PF-04691502 is 2289-5.

Question 2

Is PF-04691502 in stock?

Accepted Answer

PF-04691502 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is PF-04691502 used for?

Accepted Answer

A potent, ATP-competitive PI3K/mTOR dual inhibitor with broad antitumor activity. PF-04691502 potently inhibits recombinant class I PI3K and mTOR in biochemical assays and suppresses transformation of avian fibroblasts mediated by wild-type PI3K γ, δ, or mutant PI3Kα.

Question 4

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 5

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

PF-04691502

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

KIAA1598 Recombinant Protein (Human)

TMEM22 3'UTR Luciferase Stable Cell Line

R4RL2, CT (RTN4RL2, NGRH1, NGRL3, Reticulon-4 receptor-like 2, Nogo receptor-like 3, Nogo-66 receptor homolog 1, Nogo-66 receptor-related protein 2) (MaxLight 405) discontinued

Human MTA2 Knockout A549 cell line

Hsa-miR-602 antagomir

Hsa-miR-602 antagomir